FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention proposes applying 1-benzylindonyl-3-thioacetic acid tris-(2-hydroxyethyl)ammonium salt as an anti-tumor agent that is known early as a stabilizing agent of cellular membranes. Also, this agent exerts inhibitory effect on metastasizing process. Agent potentiates therapeutic effect of other anti-cancer preparation.
EFFECT: valuable medicinal anti-tumor property of agent, expanded assortment of agents of claimed designation.
5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR AGENT | 2003 |
|
RU2253446C1 |
ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
METHOD FOR TREATING AUTOIMMUNE DISEASES | 2003 |
|
RU2252760C1 |
ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
IMMUNODEPRESSANT | 2002 |
|
RU2228178C1 |
PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
METHOD FOR POTENTIATING ACTIVITY OF ANTI-TUMOUR CYTOTOXIC PREPARATIONS | 2017 |
|
RU2714140C2 |
METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
MEANS FOR INHIBITION OF METASTASIS IN LUNGS | 2016 |
|
RU2632703C1 |
METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
Authors
Dates
2004-11-27—Published
2003-12-02—Filed